Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
HIV Clinical Trials
|
October 30, 2003
Clinical impact of double protease inhibitor boosting with lopinavir/ritonavir and amprenavir as part of salvage antiretroviral therapy
Mona Loutfy, Janet Raboud, Courtney Thompson, et al.
Trials
|
November 24, 2014
A multicentre phase III randomised controlled single-masked clinical trial evaluating the clinical efficacy and safety of light-masks at preventing dark-adaptation in the treatment of early diabetic macular oedema (CLEOPATRA): study protocol for a randomised controlled trial
Sobha Sivaprasad, Geoffrey Arden, A Toby Prevost, et al.
The British Journal of Ophthalmology
|
September 15, 2017
Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. A multicentre, randomised controlled trial: design and methodology
Gus Gazzard, Evgenia Konstantakopoulou, David Garway-Heath, et al.
Investigative Ophthalmology & Visual Science
|
September 19, 2019
Binocular Inhibition of Reading in Macular Telangiectasia Type 2
Simone Tzaridis, Philipp Herrmann, Peter Charbel Issa, et al.
BMJ Open
|
November 29, 2015
Randomised, single-masked non-inferiority trial of femtosecond laser-assisted versus manual phacoemulsification cataract surgery for adults with visually significant cataract: the FACT trial protocol
Alexander C Day, Jennifer M Burr, Catey Bunce, et al.
Lancet (London, England)
|
March 14, 2019
Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Gus Gazzard, Evgenia Konstantakopoulou, David Garway-Heath, et al.
Ophthalmic Research
|
July 29, 2019
New Technologies for Outcome Measures in Retinal Disease: Review from the European Vision Institute Special Interest Focus Group
Maria Della Volpe-Waizel, Ghislaine L Traber, Peter Maloca, et al.
Health Technology Assessment (Winchester, England)
|
July 3, 2019
Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Gus Gazzard, Evgenia Konstantakopoulou, David Garway-Heath, et al.
Ophthalmic Research
|
January 15, 2020
New Technologies for Outcome Measures in Glaucoma: Review by the European Vision Institute Special Interest Focus Group
Ghislaine L Traber, Maria Della Volpe-Waizel, Peter Maloca, et al.
JAMA Ophthalmology
|
April 15, 2016
The Effect of Multispot Laser Panretinal Photocoagulation on Retinal Sensitivity and Driving Eligibility in Patients With Diabetic Retinopathy
Mala Subash, Oliver Comyn, Ahmed Samy, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
HIV Clinical Trials
|
October 30, 2003
Clinical impact of double protease inhibitor boosting with lopinavir/ritonavir and amprenavir as part of salvage antiretroviral therapy
Mona Loutfy, Janet Raboud, Courtney Thompson, et al.
Trials
|
November 24, 2014
A multicentre phase III randomised controlled single-masked clinical trial evaluating the clinical efficacy and safety of light-masks at preventing dark-adaptation in the treatment of early diabetic macular oedema (CLEOPATRA): study protocol for a randomised controlled trial
Sobha Sivaprasad, Geoffrey Arden, A Toby Prevost, et al.
The British Journal of Ophthalmology
|
September 15, 2017
Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. A multicentre, randomised controlled trial: design and methodology
Gus Gazzard, Evgenia Konstantakopoulou, David Garway-Heath, et al.
Investigative Ophthalmology & Visual Science
|
September 19, 2019
Binocular Inhibition of Reading in Macular Telangiectasia Type 2
Simone Tzaridis, Philipp Herrmann, Peter Charbel Issa, et al.
BMJ Open
|
November 29, 2015
Randomised, single-masked non-inferiority trial of femtosecond laser-assisted versus manual phacoemulsification cataract surgery for adults with visually significant cataract: the FACT trial protocol
Alexander C Day, Jennifer M Burr, Catey Bunce, et al.
Lancet (London, England)
|
March 14, 2019
Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Gus Gazzard, Evgenia Konstantakopoulou, David Garway-Heath, et al.
Ophthalmic Research
|
July 29, 2019
New Technologies for Outcome Measures in Retinal Disease: Review from the European Vision Institute Special Interest Focus Group
Maria Della Volpe-Waizel, Ghislaine L Traber, Peter Maloca, et al.
Health Technology Assessment (Winchester, England)
|
July 3, 2019
Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Gus Gazzard, Evgenia Konstantakopoulou, David Garway-Heath, et al.
Ophthalmic Research
|
January 15, 2020
New Technologies for Outcome Measures in Glaucoma: Review by the European Vision Institute Special Interest Focus Group
Ghislaine L Traber, Maria Della Volpe-Waizel, Peter Maloca, et al.
JAMA Ophthalmology
|
April 15, 2016
The Effect of Multispot Laser Panretinal Photocoagulation on Retinal Sensitivity and Driving Eligibility in Patients With Diabetic Retinopathy
Mala Subash, Oliver Comyn, Ahmed Samy, et al.
Page
of 4